Affiliations 

  • 1 Vardhman Mahavir Medical College & Safdarjung Hospital, Department of Nephrology and Renal Transplantation Medicine, New Delhi, India
  • 2 International Medical University, Department of Orthopaedics, Kuala Lumpur, Malaysia. ampalsurgery@gmail.com
  • 3 Vardhman Mahavir Medical College & Safdarjung Hospital, Central Institute of Orthopaedics, New Delhi, India
  • 4 Hospital Sungai Buloh & Monash University, Kuala Lumpur, Malaysia
  • 5 Agartala Government Medical College, Tripura, India
  • 6 Universiti Kebangsaan Malaysia, Hospital Canselor Tuanku Muhriz, Faculty of Medicine, Department of Medicine, Kuala Lumpur, Malaysia
  • 7 United Nations University, International Institute for Global Health, Kuala Lumpur, Malaysia
  • 8 International Medical University, Department of Orthopaedics, Kuala Lumpur, Malaysia
Med J Malaysia, 2025 Jan;80(1):102-107.
PMID: 39812436

Abstract

INTRODUCTION: This study focuses on the association between musculoskeletal disorders and chronic kidney disease (CKD), specifically end-stage kidney disease (ESKD). Its primary objective is to explore the spectrum of musculoskeletal disorders and to identify their prevalence rates and symptoms within diverse CKD subpopulations.

MATERIALS AND METHODS: The screening process yielded 13 studies conducted in various countries and regions. These studies, employing designs such as cross-sectional, cohort, and clinical trials, focused on CKD patients across different stages, including early and late-stage CKD.

RESULTS: The study revealed that musculoskeletal disorders are a considerable concern within the CKD population but are insufficiently explored among ESKD patients. Common musculoskeletal disorders identified include osteoarthritis, osteoporosis, fibromyalgia, carpopedal spasm, and chronic musculoskeletal pain syndrome. The prevalence of these disorders varied, with sub-group analysis revealing higher prevalence among hemodialysis patients compared to preand non-dialysis patients. While musculoskeletal pain remains consistent across CKD stages, potential confounding factors, such as palliative care settings and mobility issues warrant careful consideration.

CONCLUSION: The study underscores the importance of understanding and addressing musculoskeletal disorders in the CKD population, emphasizing the need for tailored interventions and future research endeavors.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.